Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome

Heart

Volumn 98, Issue 1, 2012, Pages 37-41

  De Mulder, Maarten ^a   Oemrawsingh, Rohit M ^b,c   Stam, Frank ^a   Boersma, Eric ^b   Umans, Victor A ^a  

^a Northwest Clinics   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STROKE;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; DIABETIC CARDIOMYOPATHIES; EARLY DIAGNOSIS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ROC CURVE;

EID: 84155164865     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300163     Document Type: Article

References (27)

1. Bolk J, van der Ploeg T, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001;79:207-14. (Pubitemid 32673682)
2. Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41:1-7. (Pubitemid 36044395)
3. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8. (Pubitemid 30128815)
4. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86. (Pubitemid 40847785)
5. de Mulder M, Cornel JH, van der Ploeg T, et al. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart J 2010;160:412-19.
6. de Mulder M, Oemrawsingh RM, Stam F, et al. Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey. Crit Pathw Cardiol 2009;8:66-70.
7. Zhao YT, Weng CL, Chen ML, et al. Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials. Heart 2010;96:1622-6.
8. Anantharaman R, Heatley M, Weston CF. Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target? Heart 2009;95:697-703.
9. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;117:1610-19. (Pubitemid 351440650)
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
11. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
12. Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136. (Pubitemid 46137814)
13. de Mulder M, Umans VA, Stam F, et al. Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial. Diabet Med 2011;28:1168-75.
14. American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care 2010;33:S11-61.
15. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: WHO Document Production Services. 2006. ISBN 978 92 4 159493 6.
16. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4. (Pubitemid 34694020)
17. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880-90. (Pubitemid 39452604)
18. de la Hera JM, Delgado E, Hernandez E, et al. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. Eur Heart J 2009;30:2614-21.
19. Panzer S, Kronik G, Lechner K, et al. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 1982;59:1348-50. (Pubitemid 12074869)
20. Roberts WL, Safar-Pour S, De BK, et al. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 2005;51:776-8. (Pubitemid 40463930)
21. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010;152:770-7.
22. Bronisz A, Kozinski M, Magielski P, et al. Value of oral glucose tolerance test in the acute phase of myocardial infarction. Cardiovasc Diabetol 2011;10:21.
23. Jimenez-Navarro MF, Garcia-Pinilla JM, Garrido-Sanchez L, et al. Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention. Int J Cardiol 2010;142:245-9.
24. Ko GT, Chan JC, Woo J, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998;35:62-7. (Pubitemid 28043626)
25. Wallander M, Malmberg K, Norhammar A, et al. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008;31:36-8.
26. Hofsten DE, Logstrup BB, Moller JE, et al. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis. JACC Cardiovasc Imaging 2009;2:592-9.
27. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. (Pubitemid 28350165)